You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Claims for Patent: 11,141,457

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,141,457

Title:	Oral octreotide therapy and contraceptive methods
Abstract:	This invention relates to methods of administering oral octreotide therapy to a female subject relating to avoidance of combined oral contraceptives or use of a back-up method for contraception.
Inventor(s):	Haviv; Asi (Gan-Shlomo, IL), Stevens; Ruth Engle (Long Beach, WA), Dawkins; Jennings Ray (Coats, NC)
Assignee:	AMRYT ENDO, INC. (Needham, MA)
Application Number:	17/135,328
Patent Claims:	1. A method of administering oral octreotide to a female subject in need thereof wherein said subject is also in need of a contraceptive method, comprising (a) administering to the subject oral octreotide; and (b) counseling the subject to avoid concomitant use of a combined oral contraceptive. 2. The method of claim 1, wherein the combined oral contraceptive comprises levonorgestrel. 3. A method of administering oral octreotide to a female subject in need thereof wherein said subject is administered a combined oral contraceptive, comprising (a) administering to the subject oral octreotide; and (b) counseling the subject to use a back-up method of contraception or to use an alternative non-hormonal method of contraception. 4. The method of claim 3, wherein the combined oral contraceptive comprises levonorgestrel. 5. The method of claim 1, wherein the subject has acromegaly. 6. The method of claim 1, wherein the subject has severe diarrhea or flushing episodes associated with metastatic carcinoid tumor. 7. The method of claim 3, wherein the subject has acromegaly. 8. The method of claim 3, wherein the subject has severe diarrhea or flushing episodes associated with metastatic carcinoid tumor. 9. A method of administering oral octreotide to a female subject in need thereof wherein said subject is also in need of a contraceptive method, comprising (a) administering to the subject oral octreotide; and (b) counseling the subject to avoid concomitant use of a contraceptive which comprises levonorgestrel or to use a back-up method of contraception or to use an alternative method of contraception. 10. The method of claim 9, wherein the contraceptive which comprises levonorgestrel is an oral contraceptive. 11. The method of claim 9, wherein the contraceptive which comprises levonorgestrel is not an oral contraceptive. 12. The method of claim 11, wherein the contraceptive is an intrauterine device.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.